Martin, Felicity
Conti, Janet
McCormack, Madalyn
Heruc, Gabriella
Prnjak, Katarina
Barns, Rebecca
Hay, Phillipa https://orcid.org/0000-0003-0296-6856
Funding for this research was provided by:
Australia and New Zealand Academy for Eating Disorders
Article History
Received: 16 September 2025
Accepted: 8 January 2026
First Online: 3 February 2026
Declarations
:
: This research was approved by the HREC at the Western Sydney University (H15252) and all participants provided consent to participate. In accordance with this all-transcript data has been de-identified through pseudonyms and participants were invited to remove any further identifying data and to review the analysis for consistency and resonance with their experiences.
: The authors FM, JC, and MM declare that they have no competing interests. Author PH has received sessional fees from the Therapeutic Guidelines publication and the Health Education and Training Institute (HETI, NSW), and royalties/honoraria from Hogrefe and Huber, McGraw Hill Education, Blackwell Scientific Publications, BioMed Central, and PLOS Medicine. She has been a consultant to Takeda Pharmaceuticals and is on the Scientific Advisory Board of Tryptamine Therapeutics. Author GH was employed by ANZAED as the Credentialing Director for the Credential program with funding support from the Australian Government Department of Health and Aged Care.